Exchange: NASDAQ·Updated 07:34 PM EDT
News
all
press releases
Progyny (PGNY) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks
IVZ, HUBS, HNGE and PGNY make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
Zacks
Why Progyny Stock Plunged, Then Gradually Recovered Today
Key PointsProgyny's sales and adjusted earnings per share grew by 5% and 15% in the second quarter...
Nasdaq News: Markets
Progyny (PGNY) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Progyny (PGNY) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks
Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates
Progyny (PGNY) delivered earnings and revenue surprises of +7.84% and +0.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
MTD Second Quarter Earnings Beat Estimates on China-Led Sales Growth
MTD beats Q2 earnings estimates as strong China and emerging-market sales fuel growth, while the company raises its 2026 sales and earnings outlook.
Zacks
Organon (OGN) Lags Q2 Earnings Estimates
Organon (OGN) delivered earnings and revenue surprises of -2.30% and +1.09%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Teladoc (TDOC) Reports Q2 Loss, Lags Revenue Estimates
Teladoc (TDOC) delivered earnings and revenue surprises of +12.50% and -1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks

Advertisement|Remove ads.